A team of researchers has warned that dormant cancer cells in the body may be awakened by respiratory illnesses like Covid and the flu and start to spread, saying their study findings showed these cells not just spreading, but “rapidly proliferating”, reports The Independent.
They noted that the inflammatory process, which happens when the body’s immune system is activated in response to an infection, wakes up disseminated cancer cells (DCCs): these are cells that have broken away from a primary tumour that can spread to distant organs, often lying dormant for extended periods.
The researchers, which included teams from the University of Colorado School of Medicine, Utrecht University and University College London, said that Covid or flu infection in mice sparked a massive expansion of metastatic cells in the lungs within days of infection and the appearance of metastatic lesions within two weeks.
However, two population studies also showed the risk of a virus waking up dormant cancer cells is not just a problem in mice.
Their analysis, published in the journal Nature, revealed the dormant cells were awoken by interleukin-6 (IL-6) – a protein that immune cells release in response to infections or injuries.
The results are “really quite dramatic”, said James DeGregori, a cancer biologist at the University of Colorado School of Medicine in Aurora, and an author of the study.
“Respiratory virus infections didn’t just awaken the cells,” he added. “These viruses also caused them to proliferate, or multiply to enormous numbers.”
He said dormant cancer cells “are like the embers left in an abandoned campfire, and respiratory viruses are like a strong wind that reignites the flames”.
Remission in patients
The study’s authors suggested that respiratory infections in cancer patients in remission are linked to cancer metastasis – where cancer cells spread from the original tumour to other parts of the body.
The researchers used data from patients who were diagnosed with cancer and other diseases, before the pandemic, from the UK Biobank, which holds data from more than 500 000 people.
Their aim was to investigate whether a Covid infection increased the risk of cancer-related mortality among participants with cancer.
They focused on cancer survivors who had been diagnosed at least five years before the pandemic, ensuring they were probably in remission. Among them, 487 individuals tested positive for Covid, and these were compared with 4 350 matched controls who tested negative.
After excluding those cancer patients who died from Covid, the researchers found that cancer patients who tested positive for Covid faced an almost doubling of risk of dying from cancer compared with those patients with cancer who had tested negative.
The second population study used data from the US Flatiron Health database and focused on data from female breast cancer patients seen at 280 US cancer clinics.
They compared the incidence of metastases to the lung among those who did not have Covid (36,216) and patients that tested positive (532).
Participants were followed up just more than four years later: those who came down with Covid were almost 50% more likely to experience metastatic progression to the lungs compared with patients with breast cancer without a diagnosis of Covid.
“Our findings suggest that cancer survivors may be at increased risk of metastatic relapse after common respiratory viral infections,” said Dr Roel Vermeulen of Utrecht University. “It is important to note that our study focused on the period before Covid-19 vaccines were available.”
“Our findings indicate that individuals with a history of cancer may benefit from taking precautions against respiratory viruses, such as vaccination when available, and discussing any concerns with their healthcare providers,” said Dr Julio Aguirre-Ghiso of Montefiore Einstein Comprehensive Cancer Centre’s Cancer Dormancy Institute, a co-leader of the study.
See more from MedicalBrief archives:
Severe outcomes in vaccinated cancer patients with breakthrough Covid
Cancer an independent risk factor for poor Covid-19 outcomes — Penn study
Cancer survivors at higher flu hospitalisation and mortality risk. Also severe Covid?